Alps Group Inc (ALPS) vs Pliant Therapeutics, Inc. (PLRX)
A side-by-side comparison of Alps Group Inc and Pliant Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ALPS
Alps Group Inc
$0.39HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
PLRX
Pliant Therapeutics, Inc.
$1.03HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — ALPS vs PLRX
growth of $100 · dividends reinvested · last 1yALPS -96.7% (-96.7%/yr)PLRX -43.1% (-43.1%/yr)PLRX compounded faster over this window
Log scale — wide-divergence pair
ALPS PLRX
ALPS vs PLRX: by the numbers
- •ALPS is the larger company ($64M vs $64M market cap).
- •Both run net losses; PLRX's is the smaller (0.00% vs -41.36% net margin).
Metrics side by side
Valuation
| Metric | ALPS | PLRX |
|---|---|---|
| P/B ratio | N/A | 0.43 |
Profitability
| Metric | ALPS | PLRX |
|---|---|---|
| Gross margin | 32.09% | 0.00% |
| Operating margin | -69.62% | 0.00% |
| Net margin | -41.36% | 0.00% |
| ROE | N/A | -62.81% |
| ROIC | N/A | -56.22% |
Growth (annualized)
| Metric | ALPS | PLRX |
|---|---|---|
| Total return CAGR (5Y) | N/A | -43.17% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.